Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Praet

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Open Forum Infectious Diseases|April 17, 2020
Quantitative Benefit-Risk Models Used for Rotavirus Vaccination: A Systematic ReviewHugo Arlegui, Gaëlle Nachbaur, Nicolas Praet, et al.
Vaccine|October 24, 2018
Reply to Lee et al.'s letter to the editor pertaining to our publication entitled "Pain caused by measles, mumps, and rubella vaccines: A systematic literature review"Corinne Willame, Lan Lin, Volker Vetter, et al.
Expert Review of Vaccines|January 29, 2019
Introducing new vaccines in low- and middle-income countries: challenges and approachesAdrienne Guignard, Nicolas Praet, Viviane Jusot, et al.
Epidemiology (Cambridge, Mass.)|February 16, 2006
Estimating disease prevalence in a Bayesian framework using probabilistic constraintsDirk Berkvens, Niko Speybroeck, Nicolas Praet, et al.
Clinical Therapeutics|September 29, 2020
Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit-Risk Models: The Example of Rotavirus Vaccination in FranceHugo Arlegui, Gaëlle Nachbaur, Nicolas Praet, et al.
Drug Safety|September 12, 2020
Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)Hugo Arlegui, Kaatje Bollaerts, Vincent Bauchau, et al.
Vaccine|September 13, 2017
Pain caused by measles, mumps, and rubella vaccines: A systematic literature reviewCorinne Willame, Ouzama Henry, Lan Lin, et al.
Drug Safety|September 11, 2020
Benefit-Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit-Risk Models Applied to VaccinesHugo Arlegui, Kaatje Bollaerts, Francesco Salvo, et al.
Parasites & Vectors|January 24, 2014
Epidemiology and genetic diversity of Taenia asiatica: a systematic reviewAnita Ale, Bjorn Victor, Nicolas Praet, et al.
Plos Neglected Tropical Diseases|July 7, 2015
Taenia solium Human Cysticercosis: A Systematic Review of Sero-epidemiological Data from Endemic Zones around the WorldMarco Coral-Almeida, Sarah Gabriël, Emmanuel Nji Abatih, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Open Forum Infectious Diseases|April 17, 2020
Quantitative Benefit-Risk Models Used for Rotavirus Vaccination: A Systematic ReviewHugo Arlegui, Gaëlle Nachbaur, Nicolas Praet, et al.
Vaccine|October 24, 2018
Reply to Lee et al.'s letter to the editor pertaining to our publication entitled "Pain caused by measles, mumps, and rubella vaccines: A systematic literature review"Corinne Willame, Lan Lin, Volker Vetter, et al.
Expert Review of Vaccines|January 29, 2019
Introducing new vaccines in low- and middle-income countries: challenges and approachesAdrienne Guignard, Nicolas Praet, Viviane Jusot, et al.
Epidemiology (Cambridge, Mass.)|February 16, 2006
Estimating disease prevalence in a Bayesian framework using probabilistic constraintsDirk Berkvens, Niko Speybroeck, Nicolas Praet, et al.
Clinical Therapeutics|September 29, 2020
Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit-Risk Models: The Example of Rotavirus Vaccination in FranceHugo Arlegui, Gaëlle Nachbaur, Nicolas Praet, et al.
Drug Safety|September 12, 2020
Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)Hugo Arlegui, Kaatje Bollaerts, Vincent Bauchau, et al.
Vaccine|September 13, 2017
Pain caused by measles, mumps, and rubella vaccines: A systematic literature reviewCorinne Willame, Ouzama Henry, Lan Lin, et al.
Drug Safety|September 11, 2020
Benefit-Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit-Risk Models Applied to VaccinesHugo Arlegui, Kaatje Bollaerts, Francesco Salvo, et al.
Parasites & Vectors|January 24, 2014
Epidemiology and genetic diversity of Taenia asiatica: a systematic reviewAnita Ale, Bjorn Victor, Nicolas Praet, et al.
Plos Neglected Tropical Diseases|July 7, 2015
Taenia solium Human Cysticercosis: A Systematic Review of Sero-epidemiological Data from Endemic Zones around the WorldMarco Coral-Almeida, Sarah Gabriël, Emmanuel Nji Abatih, et al.
Pageof 7